Homotypic cell cannibalism, a cell‐death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
Year: 2012
Type: article
Abstract: Pancreatic adenocarcinoma (PDAC) is an extremely deadly disease for which all treatments available have failed to improve life expectancy significantly. This may be explained by the high metastatic potential of PDAC cells, which results from their dedifferentiation towards a mesenchymal phenotype. Some PDAC present cell-in-cell structures whose origin and significance are currently unknown. We show here that cell-in-cells form after homotypic cell cannibalism (HoCC). We found PDAC patients whose tumours display HoCC develop less metastasis than those without. In vitro, HoCC was promoted by inactivation of the nuclear protein 1 (Nupr1), and was enhanced by treatment with transforming growth factor β. HoCC ends with death of PDAC cells, consistent with a metastasis suppressor role for this phenomenon. Hence, our data indicates a protective role for HoCC in PDAC and identifies Nupr1 as a molecular regulator of this process.
Source: EMBO Molecular Medicine
Institutions: Centre National de la Recherche Scientifique, Inserm, Aix-Marseille Université, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Centre hospitalier de l'Université Laval, Centre de recherche du CHU de Québec-Université Laval, Université de Lyon, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Mayo Clinic, Institut Gustave Roussy, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Université Paris Descartes
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $7,990
Funders: Mayo Clinic, Association pour la Recherche sur le Cancer, Institut National de la Santé et de la Recherche Médicale, Ligue Contre le Cancer, Canceropôle PACA, Institut National Du Cancer, National Institutes of Health, Center for Cell Signaling in Gastroenterology, Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases
OpenAlex ID: W2137811752
